TSH Biopharm Corporation Limited

TPEX:8432 Voorraadrapport

Marktkapitalisatie: NT$2.5b

TSH Biopharm Beheer

Beheer criteriumcontroles 2/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Sze-Yuan Yang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO5.8yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn4.6yrs
Gemiddelde ambtstermijn bestuur1.1yrs

Recente managementupdates

Recent updates

Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Feb 18
Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

Jan 21
Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Dec 16
TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Analyse CEO-vergoeding

Hoe is Sze-Yuan Yang's beloning veranderd ten opzichte van TSH Biopharm's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

NT$88m

Mar 31 2024n/an/a

NT$92m

Dec 31 2023n/an/a

NT$62m

Sep 30 2023n/an/a

NT$54m

Jun 30 2023n/an/a

NT$55m

Mar 31 2023n/an/a

NT$53m

Dec 31 2022n/an/a

NT$62m

Sep 30 2022n/an/a

NT$68m

Jun 30 2022n/an/a

NT$60m

Mar 31 2022n/an/a

NT$57m

Dec 31 2021NT$6mNT$4m

NT$47m

Sep 30 2021n/an/a

NT$47m

Jun 30 2021n/an/a

NT$53m

Mar 31 2021n/an/a

NT$48m

Dec 31 2020NT$6mNT$5m

NT$62m

Compensatie versus markt: Insufficient data to establish whether Sze-Yuan's total compensation is reasonable compared to companies of similar size in the TW market.

Compensatie versus inkomsten: Sze-Yuan's compensation has been consistent with company performance over the past year.

CEO

Sze-Yuan Yang

5.8yrs

Tenure

NT$5,724,000

Compensatie

Ms. Sze-Yuan Yang serves as General Manager at TSH Biopharm Corporation Limited since January 17, 2019. She studied at Institute of Pharmacology, National Yangming University. She has served at TTY Pharmac...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Sze-Yuan Yang
General Manager5.8yrsNT$5.72mgeen gegevens
Xin-Yang Liu
Vice General Manager of General Administration4.6yrsNT$3.07mgeen gegevens
Jung-Liang Kao
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Chen-Ju Kan
Senior Manager of the Accounting Departmentno datageen gegevensgeen gegevens
Jian-Rong Huang
Sales Division Director4.6yrsgeen gegevensgeen gegevens
Hsin-Young Liu
Company Secretary4.5yrsgeen gegevensgeen gegevens

4.6yrs

Gemiddelde duur

Ervaren management: 8432's management team is considered experienced (4.6 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Chuan-Quan Lin
Chairman4.5yrsgeen gegevensgeen gegevens
Kang-Chi Chou
Representative Director4.5yrsgeen gegevensgeen gegevens
Carl Hsiao
Representative Director4.5yrsgeen gegevens0.088%
NT$ 2.2m
Rwei-Syun Chen
Independent Directorno datageen gegevensgeen gegevens
Yaw-Bin Huang
Independent Directorno datageen gegevensgeen gegevens
Te-Yu Chou
Independent Director1.1yrsgeen gegevensgeen gegevens
Yong-Liang Wu
Director1.1yrsgeen gegevensgeen gegevens
Yuen-Liang Lai
Independent Directorless than a yeargeen gegevensgeen gegevens
Shiow-Ming Wu
Independent Directorless than a yeargeen gegevensgeen gegevens

1.1yrs

Gemiddelde duur

Ervaren bestuur: 8432's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.